{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:19:05Z","timestamp":1789993145206,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.transci.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T21:45:43Z","timestamp":1364420743000},"page":"482-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India"],"prefix":"10.1016","volume":"49","author":[{"given":"N.","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Coshic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Borgohain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.03.004_b0005","unstructured":"Global blood safety and availability: facts and figures from the 2007 blood safety survey. WHO Fact Sheet #279, November 2009."},{"issue":"5","key":"10.1016\/j.transci.2013.03.004_b0010","first-page":"476","article-title":"An example of traceability up to the patient","volume":"14","author":"Piotrowicz-Theizen","year":"2004","journal-title":"STP Pharma Pratiques"},{"key":"10.1016\/j.transci.2013.03.004_b0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(95)91002-6","article-title":"Hepatitis-C transmission associated with intravenous immunoglobulins","volume":"345","author":"Yu","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.transci.2013.03.004_b0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1537-2995.2010.02801.x","article-title":"Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study","volume":"51","author":"Meena","year":"2010","journal-title":"Transfus"},{"key":"10.1016\/j.transci.2013.03.004_b0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c621","article-title":"HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes","volume":"340","author":"Jha","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2013.03.004_b0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1537-2995.2002.00200.x","article-title":"International application of the incidence rate and window-period model (editorial). National Heart, Lung and Blood Institute Retrovirus Epidemiology Donor Study","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.03.004_b0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated windowperiod risk in the American Red Cross Blood Donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.03.004_b0040","series-title":"Molecular biology in blood transfusion","article-title":"Nucleic acid amplification testing of blood donations","author":"Busch","year":"2000"},{"key":"10.1016\/j.transci.2013.03.004_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new safety strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.03.004_b0050","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/JCM.40.7.2408-2419.2002","article-title":"Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA","volume":"40","author":"Giachetti","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.transci.2013.03.004_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2009.10.015","article-title":"Nucleic acid testing (NAT) in high prevalence-low resource settings","volume":"38","author":"Ekiaby","year":"2010","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.transci.2013.03.004_b0060","first-page":"140","article-title":"Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors","volume":"127","author":"Makroo","year":"2008","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.transci.2013.03.004_b0065","series-title":"Examining the health disparities research plan of the National Institutes of Health: Unfinished business","first-page":"129","article-title":"Overview of health disparities","author":"Adler","year":"2006"},{"key":"10.1016\/j.transci.2013.03.004_b0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10461-005-9000-7","article-title":"Housing status and HIV risk behaviors: Implications for prevention and policy","volume":"9","author":"Aidala","year":"2005","journal-title":"AIDS Behav"},{"key":"10.1016\/j.transci.2013.03.004_b0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa040085","article-title":"Detection of HIV-1 and HCV infections among antibody negative blood donors by nucleic acid-amplification testing","volume":"51","author":"Stramer","year":"2004","journal-title":"New Eng J"},{"key":"10.1016\/j.transci.2013.03.004_b0080","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1537-2995.2008.01718.x","article-title":"Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus","volume":"48","author":"Hourfar","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.03.004_b0085","doi-asserted-by":"crossref","unstructured":"Japanese Red Cross NAT Screening Research Group. Microbiol Immunol 2001;45(9):667\u201372.","DOI":"10.1111\/j.1348-0421.2001.tb01300.x"},{"issue":"1","key":"10.1016\/j.transci.2013.03.004_b0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.transci.2009.05.001","article-title":"Two HBV DNA+\/HBsAg- blood donors identified by HBV NAT in Shenzhen","volume":"41","author":"Shang","year":"2009","journal-title":"China Transfus Apher Sci"},{"key":"10.1016\/j.transci.2013.03.004_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1751-2824.2006.00030.x","article-title":"The Impact of Individual Donation NAT Screening on Blood Safety \u2013 The South African experience","volume":"1","author":"Heynes","year":"2006","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.transci.2013.03.004_b0100","first-page":"301","article-title":"Current safety of blood supply in the United States","volume":"80","author":"Dodd","year":"2004","journal-title":"J Hematol"},{"key":"10.1016\/j.transci.2013.03.004_b0105","first-page":"409","article-title":"Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in Western India","volume":"44","author":"Garg","year":"2001","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T12:50:48Z","timestamp":1539780648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1473050213000803"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.03.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}